Cefepime-enmetazobactam for complicated urinary tract infections: Redefining ESBL therapy. [PDF]
Chandra P.
europepmc +1 more source
Draft-genome sequencing of multidrug-resistant hypervirulent <i>Klebsiella pneumoniae</i> from neonatal septicaemia at SRHU, Dehradun, India. [PDF]
Sarkar I +6 more
europepmc +1 more source
Antimicrobial Resistance Patterns and Cumulative Antibiogram of Clinically Significant Bacteria From a Tertiary Hospital in Indonesia. [PDF]
Bur R +7 more
europepmc +1 more source
Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective. [PDF]
Röder J +8 more
europepmc +1 more source
Evaluation of high dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation. [PDF]
Bauman AJ +6 more
europepmc +1 more source
Time to Awaken a Forgotten Antibacterial Agent: A 10-year Nationwide Surveillance of Latamoxef Resistance in China Based on 46,716 Isolates and Establishment of Tentative Epidemiological Cut-Off Values. [PDF]
Chen P +9 more
europepmc +1 more source
Answer to November Photo Quiz: \u3cem\u3eCampylobacter jejuni\u3c/em\u3e Pleuritis [PDF]
Munson, Erik +3 more
core +1 more source
Activity of aztreonam-avibactam, cefiderocol, and cefepime-taniborbactam against a global collection of genetically characterized metallo-β-lactamase-producing Enterobacterales. [PDF]
Castanheira M +4 more
europepmc +1 more source
Optimization of cefepime dosage regimens for <i>Pseudomonas aeruginosa</i> infections in Japanese patients based on a pharmacokinetic/ pharmacodynamic analysis considering efficacy and safety: Is a 6 g daily dose and continuous infusion necessary? [PDF]
Ebihara F +5 more
europepmc +1 more source
Genetic and phenotypic characterization of the plasmid-encoded NDM-80 metallo-β-lactamase in <i>Escherichia coli</i> isolated from a pediatric patient. [PDF]
Zhou J +8 more
europepmc +1 more source

